Canada Faces Shortage of Medication to Treat Coronary Heart Artery Disease

Canada Faces Shortage of Medication to Treat Coronary Heart Artery Disease
Nitroglycerin sublingual spray is seen in a file photo. Health Canada says the country is facing a shortage of nitroglycerin tablets due to an increase in demand and a shortage of key ingredients of the spray version of the drug. (Handout via Health Canada)
Matthew Horwood
5/15/2023
Updated:
5/15/2023
0:00
Health Canada says the country is facing a shortage of nitroglycerin tablets—which are used to treat chest pain for people with coronary heart artery disease—due to an increase in demand and a shortage of key ingredients of the spray version of the drug.

“Together with its partners, Health Canada is looking at ways to conserve existing supply, expedite resupplies to hospitals and pharmacies, and access foreign-authorized supply or alternatives, where possible,” Health Canada said in a press release on May 10.

An original advisory from March 17, 2023, said that Canada was experiencing a shortage of the spray version of nitroglycerin due to supply issues and an increase in demand.

Health Canada said they were working alongside stakeholders such as the Canadian Pharmacists Association, the Canadian Cardiovascular Society, and the Heart & Stroke Foundation to find ways to conserve existing supplies and obtain new sources of the medication.

Health Canada told the Epoch Times that the three companies that market Nitroglycerin Sublingual Spray in Canada—Mylan, Sandoz, and Sanofi—are all reporting shortages due to supply issues with the raw materials used to make the sprays, as well as an increase in demand.

Health Canada said if Canadians have concerns with the shortage, they should speak with their health-care professional about how best to manage any impact of it, only obtain the amount of product they need, and keep expired products and check Health Canada’s website to determine whether the expiry date of their product has been extended.
Canadian Cardiovascular Society President Michelle Graham told the Epoch Times she attributed the increased demand for the medicine to Canada’s aging population and people missing medical appointments due to COVID-19.

“We’ve been through a global pandemic where people have been at various points, actually scared to contact the medical system because they’re scared of catching COVID,” she said.

“The decreased overall contact of the health system over the past few years has perhaps led to risk factors that would otherwise be attended to early and well-managed, but have now had a couple of years to do things to people,” she said.

Matthew Horwood is a reporter based in Ottawa.
Related Topics